Peer-reviewed analysis of OpenSecrets/Center for Responsive Politics and Senate Office of Public Records data: $4.7 billion in pharmaceutical and health-product federal lobbying from 1999-2018, averaging $233 million per year, the most of any industry.
the pharmaceutical and health product industry spent $4.7 billion on federal lobbying from 1999 to 2018
JAMA Intern Med 2020;180(5):688-697 (PMC full text)
Peer-reviewed analysis of OpenSecrets/Center for Responsive Politics and Senate Office of Public Records data: $4.7 billion in pharmaceutical and health-product federal lobbying from 1999-2018, averaging $233 million per year, the most of any industry. Uses the same underlying OpenSecrets/Senate LD-2 disclosure data the flag asks for; annual OpenSecrets series pages themselves failed to load (see notes to MME-53).
